Literature DB >> 22156923

Correlation between radiographic classification and pathological grade of portal vein wall invasion in pancreatic head cancer.

Akimasa Nakao1, Akiyuki Kanzaki, Tsutomu Fujii, Yasuhiro Kodera, Suguru Yamada, Hiroyuki Sugimoto, Shuji Nomoto, Shigeo Nakamura, Satoshi Morita, Shin Takeda.   

Abstract

OBJECTIVES: A retrospective study was performed to clarify the correlation between radiographic type of portal vein (PV) invasion and pathological grade of PV wall invasion, and their correlation with postoperative prognosis.
BACKGROUND: In many patients with pancreatic cancer, PV resection is necessary to increase resectability and obtain cancer-free margins.
METHODS: We analyzed 671 patients who had undergone surgery for invasive adenocarcinoma of the pancreas between July 1981 and June 2010. Radiographic types of PV invasion of pancreatic head cancer were classified into A (normal), B (unilateral narrowing), C (bilateral narrowing), or D (complete obstruction with collateral veins), by portography or computed tomography. Pathological grades of PV wall invasion were classified as 0 (no invasion), 1 (tunica adventitia), 2 (tunica media), or 3 (tunica intima).
RESULTS: Four hundred and sixty-three patients underwent resection, and PV resection was performed in 297. Combined arterial vessel resection was performed in 16 cases. No significant difference in operative mortality was observed between PV preservation (0.6%) and PV-only resection (2.1%), and no operative deaths occurred after 1999. Radiographic classification of PV invasion correlated with incidence of pathological PV wall invasion. In pancreatic head carcinoma, no pathological PV wall invasion was observed in type A (n = 111). Pathological PV invasion was observed in 51% of type B (42/82), 74% of type C (72/97), and 93% of type D (63/68). Long-term survival (>5 years) was observed in types A and B, and grades 0 and 1 subgroups.
CONCLUSIONS: Pancreatectomy with PV resection can be performed safely. Even in radiographic classification type B, pathological PV wall invasion was observed in 51% of patients. Long-term survival was observed in types A and B, and grades 0 and 1.

Entities:  

Mesh:

Year:  2012        PMID: 22156923     DOI: 10.1097/SLA.0b013e318237872e

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  41 in total

Review 1.  Borderline resectable pancreatic cancer: definitions and management.

Authors:  Nicole E Lopez; Cristina Prendergast; Andrew M Lowy
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

2.  Clinical benefits of neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreatic head: an observational study using inverse probability of treatment weighting.

Authors:  Tsutomu Fujii; Sohei Satoi; Suguru Yamada; Kenta Murotani; Hiroaki Yanagimoto; Hideki Takami; Tomohisa Yamamoto; Mitsuro Kanda; So Yamaki; Satoshi Hirooka; Masanori Kon; Yasuhiro Kodera
Journal:  J Gastroenterol       Date:  2016-05-11       Impact factor: 7.527

3.  Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable and borderline resectable pancreatic cancer.

Authors:  Hop S Tran Cao; Alpana Balachandran; Huamin Wang; Graciela M Nogueras-González; Christina E Bailey; Jeffrey E Lee; Peter W T Pisters; Douglas B Evans; Gauri Varadhachary; Christopher H Crane; Thomas A Aloia; Jean-Nicolas Vauthey; Jason B Fleming; Matthew H G Katz
Journal:  J Gastrointest Surg       Date:  2013-10-16       Impact factor: 3.452

Review 4.  Borderline resectable pancreatic cancer: need for standardization and methods for optimal clinical trial design.

Authors:  Matthew H G Katz; Robert Marsh; Joseph M Herman; Qian Shi; Eric Collison; Alan P Venook; Hedy L Kindler; Steven R Alberts; Philip Philip; Andrew M Lowy; Peter W T Pisters; Mitchell C Posner; Jordan D Berlin; Syed A Ahmad
Journal:  Ann Surg Oncol       Date:  2013-02-23       Impact factor: 5.344

5.  Endovascular stenting of mesenterico-portal vein stenosis to reduce blood flow through venous collaterals prior to pancreatoduodenectomy.

Authors:  Terence C Chua; Frank Wang; Richard Maher; Sivakumar Gananadha; Anubhav Mittal; Jaswinder S Samra
Journal:  Langenbecks Arch Surg       Date:  2015-05-22       Impact factor: 3.445

6.  The Landmark Series: Preoperative Therapy for Pancreatic Cancer.

Authors:  Sameer H Patel; Matthew H G Katz; Syed A Ahmad
Journal:  Ann Surg Oncol       Date:  2021-05-28       Impact factor: 5.344

7.  Preoperative radiographic vascular involvement score predicts the prognosis of resected pancreatic head adenocarcinoma.

Authors:  Shunsuke Onoe; Yuji Kaneoka; Atsuyuki Maeda; Yuichi Takayama; Yasuyuki Fukami
Journal:  Langenbecks Arch Surg       Date:  2017-03-01       Impact factor: 3.445

8.  Extended lymphadenectomy in pancreatic cancer is crucial.

Authors:  Tsutomu Fujii
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

9.  Combination of the serum carbohydrate antigen 19-9 and carcinoembryonic antigen is a simple and accurate predictor of mortality in pancreatic cancer patients.

Authors:  Mitsuro Kanda; Tsutomu Fujii; Hideki Takami; Masaya Suenaga; Yoshikuni Inokawa; Suguru Yamada; Goro Nakayama; Hiroyuki Sugimoto; Masahiko Koike; Shuji Nomoto; Yasuhiro Kodera
Journal:  Surg Today       Date:  2013-10-09       Impact factor: 2.549

10.  Pancreaticoduodenectomy with combined superior mesenteric vein resection without reconstruction is possible: A case report and review of the literature.

Authors:  Lionel Jouffret; Theophile Guilbaud; Olivier Turrini; Jean-Robert Delpero
Journal:  World J Clin Cases       Date:  2018-08-16       Impact factor: 1.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.